Skip to main content
AAPS Open
Fig. 11 | AAPS Open

Fig. 11

From: Extraction of niclosamide from commercial approved tablets into aqueous buffered solution creates potentially approvable oral and nasal sprays against COVID-19 and other respiratory infections

Fig. 11

Optical microscope images of the main components of Yomesan powder: corn starch (Lab Alley, TX); USP talc (magnesium silicate) (Medisca); anhydrous pure niclosamide (AK Sci) as aggregates of small particles.  40× objective, scale bars are 10 µm, in bright field Kohler illumination optics (Nikon Diaphot)

Back to article page